Clinical Trial Update: A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with Asthma [Phase 3]

View source ↗

Summary

Phase 3 non-inferiority trial comparing Seretide to Salmeterol/Fluticasone in asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Salmeterol/Fluticasone (fluticasone propionate/salmeterol)
• Seretide (fluticasone propionate/salmeterol)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Asthma | Phase 3 | Status: COMPLETED